Stratos Wealth Advisors, LLC Eli Lilly & CO Transaction History

Stratos Wealth Advisors, LLC

$2.13 Billion
Q3 2024

A detailed history of Stratos Wealth Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Stratos Wealth Advisors, LLC holds 4,561 shares of LLY stock, worth $3.63 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

4,561

Previous 26,512 82.8%

Holding current value

$3.63 Million

Previous $24 Million 83.17%

% of portfolio

0.19%

Previous 1.21%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$772.14 - $960.02 $16.9 Million - $21.1 Million	-21,951 Reduced 82.8%	4,561 $4.04 Million
Q2 2024 Jul 24, 2024	SELL	$724.87 - $909.04 $88,434 - $110,902	-122 Reduced 0.46%	26,512 $24 Million
Q1 2024 Apr 16, 2024	BUY	$592.2 - $792.28 $12.7 Million - $17 Million	21,406 Added 409.45%	26,634 $20.7 Million
Q4 2023 Jan 24, 2024	BUY	$525.19 - $619.13 $172,787 - $203,693	329 Added 6.72%	5,228 $3.05 Million
Q3 2023 Oct 24, 2023	SELL	$434.7 - $599.3 $111,283 - $153,420	-256 Reduced 4.97%	4,899 $2.63 Million
Q2 2023 Jul 18, 2023	BUY	$350.74 - $468.98 $16,484 - $22,042	47 Added 0.92%	5,155 $2.42 Million
Q1 2023 Apr 27, 2023	SELL	$310.63 - $364.82 $196,007 - $230,201	-631 Reduced 10.99%	5,108 $1.75 Million
Q4 2022 Jan 19, 2023	BUY	$321.55 - $374.67 $154,665 - $180,216	481 Added 9.15%	5,739 $0
Q3 2022 Oct 24, 2022	SELL	$296.48 - $337.87 $43,582 - $49,666	-147 Reduced 2.72%	5,258 $1.7 Million
Q2 2022 Jul 22, 2022	BUY	$278.73 - $327.27 $161,384 - $189,489	579 Added 12.0%	5,405 $1.75 Million
Q1 2022 Apr 26, 2022	BUY	$234.69 - $291.66 $225,302 - $279,993	960 Added 24.83%	4,826 $1.38 Million
Q4 2021 Jan 14, 2022	BUY	$224.85 - $279.04 $65,206 - $80,921	290 Added 8.11%	3,866 $1.07 Million
Q3 2021 Oct 19, 2021	SELL	$221.6 - $272.71 $156,228 - $192,260	-705 Reduced 16.47%	3,576 $826,000
Q2 2021 Jul 19, 2021	BUY	$180.55 - $233.54 $349,905 - $452,600	1,938 Added 82.71%	4,281 $983,000
Q1 2021 Apr 27, 2021	BUY	$164.32 - $212.72 $159,719 - $206,763	972 Added 70.9%	2,343 $438,000
Q4 2020 Jan 29, 2021	BUY	$130.46 - $172.63 $178,860 - $236,675	1,371 New	1,371 $232,000
Q4 2019 Jan 29, 2020	SELL	$106.92 - $132.43 $282,803 - $350,277	-2,645 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $20,183 - $21,954	-189 Reduced 6.67%	2,645 $296,000
Q2 2019 Aug 06, 2019	SELL	$110.79 - $129.32 $4,874 - $5,690	-44 Reduced 1.53%	2,834 $314,000
Q1 2019 May 07, 2019	SELL	$111.31 - $131.02 $1,892 - $2,227	-17 Reduced 0.59%	2,878 $373,000
Q4 2018 Feb 12, 2019	BUY	$105.9 - $118.64 $306,580 - $343,462	2,895 New	2,895 $335,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Advisors, LLC with notifications on news.

Account

Stratos Wealth Advisors, LLC Eli Lilly & CO Transaction History